Millipore in agreement to acquire NovAseptic

Published: 1-Aug-2005


Millipore has agreed to acquire all the shares of NovAseptic for approximately SEK720m (US$91m). Based in Gothenburg, Sweden, NovAseptic provides solutions for aseptic processing applications in biotech and pharmaceutical manufacturing operations. The company's products include a disposable sampling system (NovaSeptum) and a range of high-performance mixers, valves and connectors.

The company's other aseptic processing components include high-performance mixers and valves, optimally designed for performance and reliability in stringent drug production environments. It is expected to generate sales of around $35m in the 12 months following the closing of the transaction.

'NovAseptic's products and customer relationships are a strong strategic fit with Millipore's Bioprocess Division,' said Martin Madaus, chairman, ceo and president, Millipore. 'The acquisition will also enhance our applications expertise in the area of aseptic processing.'

You may also like